Grown Rogue International Inc (GRUSF) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Grown Rogue International Inc stock $0.09, price $0.35, that is 75.7% below the price, quality 28 out of 100. Rating: strongly overvalued. Calculated from audited financials with 15 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 9, 2026.
How to read this chart
60‑month range $0.0400 – $0.8300 · fair‑value band $0.0425 – $0.1530 · the $0.3500 price screens above the $0.0850 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 9, 2026.
Follow Grown Rogue International in your weekly email
Every Wednesday you see whether Grown Rogue International is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Grown Rogue International Inc., through its subsidiaries, engages in cultivation, manufacture, possession, sale, and distribution of marijuana in the United States. It offers flower and flower pre-rolls, as well as flower-based products.
Show moreShow less
The company also produces recreational marijuana and distributes it to dispensaries. Grown Rogue International Inc. is headquartered in Medford, Oregon.
Stock analysis
Grown Rogue International Inc (GRUSF) currently trades at $0.3500, while our model-based Fair Value estimate is $0.0850, 76% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of $0.2400 per share, and 0 of the 15 models we run sit above the $0.3500 price.
Bear case: the Economic Profit group reads lowest at $0.0400, and 15 of the 15 models stay below the price. Data coverage for this calculation is low.
Scenario range: $0.0425 (bear) to $0.1530 (bull), the price of $0.3500 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 28/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Grown Rogue International Inc reported revenue of $32.4M in FY2025 versus $9.4M in FY2021, a compound +36.4%/yr. Reported net income was $1.7M in FY2025.
Key figures
Market cap $87.4M Micro · P/S ratio 2.25 · EPS (TTM) $−0.0200 · Net margin −12.6% · Return on equity −11.3% · Return on assets (EBIT) 10.9% (5-year average) · Operating margin 7.4% · Revenue (TTM) $37.7M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 20 out of 100 (low confidence).
What moves the price
The share trades about 33% below its 52-week high and 30% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at −76%, GRUSF screens richer than that median.
Fair Value models
Bear$0.0425Fair Value $0.0850Bull$0.1530
Price $0.3500 · Downside -75.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EPV$0.0200$0.0200$0.020073
Owner Earnings$0.0500$0.1000$0.180072
Residual Income$0.0600$0.0600$0.070071
All 15 models by family
DCF Models
Owner Earnings$0.0500$0.1000$0.180072
Earnings-Based
Graham-Dodd$0.0500$0.3300$0.460063
Lynch FV$0.1300$0.1900$0.240061
PEG = 1.0$0.1300$0.1900$0.240057
EPV$0.0200$0.0200$0.020073
Multiples
P/E Multiple$0.1100$0.1500$0.190063
P/S Multiple$0.0900$0.1200$0.150057
P/B Multiple$0.2400$0.3200$0.400055
EV/EBIT$0.0500$0.0700$0.090064
EV/EBITDA$0.1100$0.1400$0.180067
EV/Revenue$0.0400$0.0500$0.070053
Asset-Based
NCAV (Graham)$0.0400$0.0500$0.070054
Economic Profit
Residual Income$0.0600$0.0600$0.070071
ROIC Compounder$0.0200$0.0200$0.020071
Growth Earnings
Growth-Adj P/E$0.1700$0.2400$0.310068
The fair value above starts from this blend and is adjusted for dilution from new shares.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.49/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+21.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+22.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+50.2%
Start year 2020 (pandemic). Over 10 years: +95.4% a year
Revenue growth 17 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+98.8%
’13
’14
’15
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 3 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: adjusted.
+39.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year+39.4%
Dividend (yield on the price)0.0%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−23% → 6%
Compare Grown Rogue International Inc with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 549 stocks
Beats the industry median on 1/10 measures
Overall it trails its industry peers.
Valuation
Quality Score28 · Bottom 25%
Fair Value upside−75.7% · Bottom 25%
Profitability
Return on assets2.8% · Below median
Net margin (12 months)−12.6% · Bottom 25%
Operating margin (12 months)7.4% · Below median
Growth and dividend
Revenue growth (quarter YoY)40.7% · Top 25%
Balance sheet
Debt / equity0.48× · Highest 25%
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
P/B4.18× · Priciest 25%
P/S (12 months)2.32× · Pricier than median
EV/EBITDA67.9× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 15
FUTURE (revenue growth)100· sector 25
PAST (return on equity)0· sector 29
HEALTH (low debt)76· sector 96
DIVIDEND (yield)0· sector 32
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Grown Rogue International Inc Fair Value". https://www.fairvalue-calculator.com/stock/GRUSF
Frequently asked questions
Is Grown Rogue International Inc (GRUSF) overvalued or undervalued?
As of Nov 9, 2026, our model estimates a fair value of $0.0850 versus a price of $0.3500, about 76% lower (overvalued).
What is the fair value of GRUSF?
Our model-based fair value for Grown Rogue International Inc is $0.0850 (as of Nov 9, 2026), built from audited fundamentals. The current price: $0.3500.
What is the quality score of GRUSF?
Grown Rogue International Inc has a Quality Score of 28/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Grown Rogue International Inc (GRUSF)?
Our model-based price target is the fair value of $0.0850 (as of Nov 9, 2026) from 15 valuation models. Cautious scenario $0.0425, optimistic scenario $0.1530. It is a calculation from audited fundamentals, not an analyst target.
What is the Grown Rogue International Inc stock forecast for 2026?
Our models put fair value at $0.0850, about 76% lower versus a price of $0.3500 (overvalued). Cautious scenario $0.0425, optimistic scenario $0.1530. The calculation is refreshed regularly with new filings.
What is the revenue of Grown Rogue International Inc (GRUSF)?
Grown Rogue International Inc reported trailing-twelve-month revenue of about $37.7M (latest available figure, as of Nov 9, 2026).
What is the intrinsic value of Grown Rogue International Inc (GRUSF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Grown Rogue International Inc it is $0.0850 per share (as of Nov 9, 2026), against a price of $0.3500. It is the blended result of 15 valuation models in 6 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Grown Rogue International Inc stock overvalued or undervalued in 2026?
As of Nov 9, 2026, GRUSF trades above its calculated fair value: price $0.3500, fair value $0.0850, a gap of about −76% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of GRUSF?
No. The price is what the market pays today ($0.3500); the fair value is what the company's own numbers justify ($0.0850). For Grown Rogue International Inc the two are $0.2650 per share apart. That gap is exactly why we show both numbers side by side.
How much is Grown Rogue International Inc worth?
The market values Grown Rogue International Inc at about $87.4M (market capitalisation, as of Nov 9, 2026). Per share that is $0.3500; our models calculate a fair value of $0.0850 per share.
What do the bullish and bearish scenarios say about GRUSF?
Our models span a range for Grown Rogue International Inc: cautious scenario $0.0425, base $0.0850, optimistic $0.1530 per share (as of Nov 9, 2026, price $0.3500). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Grown Rogue International Inc (GRUSF)?
Balance-sheet figures for Grown Rogue International Inc (as of Nov 9, 2026): return on equity −11.3%, debt of 0.48 per unit of equity. They feed the Quality Score of 28/100, which measures business quality independently of the share price.
How far is GRUSF from its 52-week high?
Grown Rogue International Inc trades at $0.3500, about 33% below its 52-week high of $0.5200 and 30% above the low of $0.2700 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0850 is for.
Which stocks are comparable to Grown Rogue International Inc?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Galderma Group, Teva Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Grown Rogue International Inc stock attractive at the current price?
The data as of Nov 9, 2026: price $0.3500, calculated fair value $0.0850 (−76%), Quality Score 28/100, from 15 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of GRUSF calculated?
We run Grown Rogue International Inc through 15 models from 6 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of $0.0850 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Grown Rogue International Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Grown Rogue International Inc (GRUSF)?
The closing price on Nov 6, 2026 was $0.3500. Our model-based fair value is $0.0850, about 76% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Grown Rogue International Inc right now?
The price sits above even our optimistic bull case ($0.1530). The favourable scenario is already priced in. Weak quality (28/100) and above fair value at the same time, the margin of safety is missing on both counts. The model range is unusually wide ($0.0425 to $0.1530). The outcome hinges heavily on assumptions, so read the point estimate with caution. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of Grown Rogue International Inc
How large is the market capitalisation of Grown Rogue International Inc (GRUSF)?
The market capitalisation of Grown Rogue International Inc is $87.4M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Grown Rogue International Inc (GRUSF)?
The price-to-sales ratio of Grown Rogue International Inc is 2.25 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Grown Rogue International Inc (GRUSF)?
Earnings per share at Grown Rogue International Inc are $−0.0200. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Grown Rogue International Inc (GRUSF)?
The net margin of Grown Rogue International Inc is −12.6% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Grown Rogue International Inc (GRUSF)?
The return on equity (ROE) of Grown Rogue International Inc is −11.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Grown Rogue International Inc (GRUSF)?
On an EBIT basis the return on assets of Grown Rogue International Inc is 10.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Grown Rogue International Inc (GRUSF)?
The operating margin of Grown Rogue International Inc is 7.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Grown Rogue International Inc (GRUSF)?
Revenue at Grown Rogue International Inc is growing +40.7% versus a year earlier (3y avg +22.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Grown Rogue International Inc (GRUSF) generate?
The free cash flow of Grown Rogue International Inc is −$1.1M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Grown Rogue International Inc (GRUSF) carry?
The net debt of Grown Rogue International Inc is $1.2M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Grown Rogue International Inc in the live analysis
One click puts Grown Rogue International Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 9, 2026